534 results on '"Kvalheim, Gunnar"'
Search Results
2. CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
3. A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
4. Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
5. Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
6. Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
7. Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
8. The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy
9. Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model
10. Human c-SRC kinase (CSK) overexpression makes T cells dummy
11. ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
12. Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
13. A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
14. Cost and clinical outcome of islet transplantation in Norway 2010‐2015
15. A novel rat fibrosarcoma cell line from transformed bone marrow-derived mesenchymal stem cells with maintained in vitro and in vivo stemness properties
16. New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia
17. Immunotherapy of Cancer — Some Up-To-Date Approaches
18. Transiently redirected T cells for adoptive transfer
19. Ameloblastin expression and putative autoregulation in mesenchymal cells suggest a role in early bone formation and repair
20. Experimental attempt to produce mRNA transfected dendritic cells derived from enriched CD34+ blood progenitor cells
21. 307.7: 3D Bioprinting of Functional Islets With Adipose-derived Stromal Cells in an Alginate/Nanocellulose Scaffold
22. Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy
23. Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
24. “Built‐in” PD‐1 blocker to rescue NK‐92 activity from PD‐L1–mediated tumor escape mechanisms
25. Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox
26. Long Term Follow up of a “Fast-DC” Immunotherapy Against WT-1 and PRAME As a Post-Remission Strategy for AML
27. Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
28. Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
29. hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
30. Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
31. Combinatorial CAR design improves target restriction
32. T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cells
33. Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer
34. Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
35. Angiogenic Molecule Expression is Downregulated in Effusions from Breast Cancer Patients
36. Preclinical full-scale evaluation of dendritic cells transfected with autologous tumor-mRNA for melanoma vaccination
37. Is Anticancer Vaccine Possible: Experimental Application of Produced mRNA Transfected Dendritic Cells Derived from Enriched CD34+ Blood Progenitor Cells
38. A WT-1 and PRAME "Fast-DC" Immunotherapy As a Potential Post-Remission Strategy for AML
39. 271 Consistent high-quality dendritic cell vaccines produced post-chemotherapy in patients with acute myeloid leukemia for use in a Phase I/II trial
40. Combinatorial CAR design improves target restriction
41. A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation
42. Disseminated tumour cells in bone marrow of patients with uveal melanoma
43. A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation
44. Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy.
45. Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies: Evaluation of five epithelial markers
46. Minimal Residual Disease in Breast Cancer
47. Side population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy
48. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study
49. Biochemical relapse in very high-risk prostate cancer after radical prostatectomy and DC-vaccine loaded with tumor RNA, hTERT, and survivin.
50. Immunogenic Properties and Antitumor Effects of Novel Therapeutic Dendritic Cell Vaccines Expressing hTERT and Survivin Antigens in Metastatic Prostate Cancer Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.